Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06182631 · ClinicalTrials.gov registry record · Phase 3
Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement
A Phase 3 study of Intravenous Administration, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 3
- Development phase
- 172
- Enrollment target
- 1
- Study location
NCT06182631 is a Phase 3 study of Intravenous Administration that has completed, run by State University of New York at Buffalo. The registered enrollment target is 172 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06182631, a Phase 3 study of Intravenous Administration, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 172 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the anxiety and pain levels of patients when using Buzzy with ice, Vapocoolant, and placebo when inserting IV's line for IV fluids and/or phlebotomy in pediatric patients in the pediatric emergency department.
Conditions Studied
Interventions
- OTHER Placebo
- DEVICE Buzzy Bee
- DRUG Vapocoolent
Study Locations (1)
New York
- Oshei Childrens Hospital - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2019-07-15 |
| Est. Completion | 2021-01-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06182631
The ClinicalTrials.gov registry entry for NCT06182631 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 172 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intravenous Administration appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06182631 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06182631 about?
NCT06182631 is a clinical study titled "Clinical Trial Testing Buzzy Bee vs Vapocoolant During IV Placement". The purpose of this study is to compare the anxiety and pain levels of patients when using Buzzy with ice, Vapocoolant, and placebo when inserting IV's line for IV fluids and/or phlebotomy in pediatric patients in the pediatric emergency department.
What is the current status of trial NCT06182631?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 172 participants. The study started on 2019-07-15. Estimated completion is 2021-01-15.
What conditions does trial NCT06182631 study?
This clinical trial studies the following conditions: Intravenous Administration.
What interventions are being tested in trial NCT06182631?
The interventions under investigation include: Placebo (OTHER), Buzzy Bee (DEVICE), Vapocoolent (DRUG).
Who is sponsoring clinical trial NCT06182631?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06182631 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.